The occurrence of adverse events in low-risk non-survivors in pediatric intensive care patients: an exploratory study

Carin W Verlaat1, Cynthia van der Starre2, Jan A Hazelzet3

  • 1Department of Intensive Care, Radboud Institute for Health Sciences, Radboud University Medical Center, P.O. Box 9101, Internal Post 709, 6500 HB, Nijmegen, The Netherlands. carin.verlaat@radboudumc.nl.

Insights

Adverse events (AEs) occurred more frequently in low-risk pediatric intensive care unit (PICU) non-survivors than in other patient groups. Some severe, preventable AEs in this group contributed to patient mortality.

Area of Science:

  • Pediatric critical care medicine
  • Patient safety research
  • Healthcare quality improvement

Background:

  • Adverse events (AEs) are common in pediatric intensive care units (PICUs), affecting 59-76% of patients.
  • The role of AEs in the mortality of low-risk PICU patients remains unclear.

Purpose of the Study:

  • To investigate the occurrence and characteristics of AEs in low-risk non-survivors (LNs) within PICUs.
  • To compare AE occurrence between LNs, low-risk survivors (LSs), high-risk non-survivors (HNs), and high-risk survivors (HSs).

Main Methods:

  • Retrospective review of patient records from two PICUs.
  • Utilized a PICU-trigger tool for AE identification.
  • Sampled 48 pediatric patients (0-18 years), stratified into four equal groups: LNs, LSs, HNs, and HSs.

Main Results:

  • A total of 45 AEs were identified in 20 patients.
  • AE occurrence was significantly higher in LNs (10/12 patients) compared to LSs (1/12) and HNs (2/12).
  • The AE rate was also significantly higher in LNs (0.12 AE/PICU day) versus LSs (0) and HNs (0).
  • Fifteen of 45 AEs were preventable, and preventable AEs contributed to mortality in 2/12 LNs.

Conclusions:

  • Low-risk PICU non-survivors experience a higher incidence of AEs compared to low-risk survivors and high-risk non-survivors.
  • Severe and preventable AEs are present in the low-risk non-survivor group.
  • These preventable AEs can impact mortality in this vulnerable patient population.

Related Concept Videos

Patient-centered Care01:13

Patient-centered Care

Patient-centered care involves delivering care beyond inpatient hospitalization. Reflective practice can enhance a patient-centered approach. Reflective practice is a process of reasoning that considers all aspects of the present situation, including practicalities, learning from personal practice, and consideration of patient needs. Patients appreciate care decisions made while considering their input. Involving the patient in their care provides the patient with a sense of contribution rather...
3.1K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
266
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
320
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
239
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
305
Types of Reports II: Incident or Occurrence Report01:21

Types of Reports II: Incident or Occurrence Report

An Incident or Occurrence Report in a healthcare setting is a crucial document used to record any unexpected occurrence that may or may not have affected a patient, employee, or visitor. Such reports are critical to improving patient safety and include all details leading up to and including the event.
Purposes:
In the healthcare industry, reports play a crucial role in documenting incidents within an agency. The primary objective of these reports is to ensure patient safety, uphold the...
1.3K